FULC
NASDAQ · Pharmaceuticals
Fulcrum Therapeutics Inc
$6.77
-0.27 (-3.84%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+741.7% upside
Low Target
$37.54
Average Target
$56.98
High Target
$60.88
Current Price
$6.77
Current
$6.77
$6.77
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Scenario Analysis
Bear Case
$37.54
454.5%
Low target
Base Case
$56.98
+741.7%
Avg target
Bull Case
$60.88
+799.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$15.74
-57.0% from high
52-Week Low
$2.32
+192.4% from low
Target vs 52W High
$56.98
+262.0% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |